Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01585129 · ClinicalTrials.gov registry record · Phase 4
Treatment Utility of Postpartum Antibiotics in Chorioamnionitis
A Phase 4 study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT01585129: Clinical Trial Phase 4 study, sponsored by Washington University School of Medicine.
NCT01585129 is a Phase 4 study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 80 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01585129, a Phase 4 study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
To determine if prophylactic postpartum antibiotics are required post-cesarean delivery for pregnancies with treated chorioamnionitis.
Primary Outcome
Endometritis is defined as uterine infection and is diagnosed by maternal temp \> 38.0C on two occasions over a 4 hour period or any temp \> 39.0C after delivery \> 12 hours after delivery. Endometritis will be managed per currently accepted endometritis protocol - (Amp 2 gQ6, Gentamicin 5 mg/kg q24, Clindamycin 900 mg q8).
Interventions
- DRUG Postpartum Antibiotics
- DRUG No postpartum antibiotics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2010-09 |
| Est. Completion | 2014-07 |
| Phase | Phase 4 |
Why NCT01585129 stopped before completion
NCT01585129 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 2 interventions - of which Postpartum Antibiotics is the first listed.
NCT01585129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01585129 about?
NCT01585129 is a clinical study titled "Treatment Utility of Postpartum Antibiotics in Chorioamnionitis". To determine if prophylactic postpartum antibiotics are required post-cesarean delivery for pregnancies with treated chorioamnionitis.
What is the current status of trial NCT01585129?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2010-09. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01585129?
The interventions under investigation include: Postpartum Antibiotics (DRUG), No postpartum antibiotics (DRUG).
Who is sponsoring clinical trial NCT01585129?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01585129's enrollment target sits among peer trials
80 946th of 2000 higher than 1,021 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia